Phase 1 trial of exercise as first-line therapy for hormone receptor (HR)–positive advanced breast cancer (TBCRC 054) Meeting Abstract
| Authors: | Iyengar, N. M.; Lavery, J. A.; Carlson, A.; Castillo, V.; Lehman, S.; Michalski, M. G.; Harrison, J.; Braun, A.; Flores, J.; Chun, S.; Lee, C. P.; Anampa, J. D. S.; Ballinger, T. J.; Sheng, J. Y.; Moskowitz, C. S.; Jones, L. W. |
| Abstract Title: | Phase 1 trial of exercise as first-line therapy for hormone receptor (HR)–positive advanced breast cancer (TBCRC 054) |
| Meeting Title: | 2025 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 43 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2025 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2025-06-01 |
| Start Page: | 1088 |
| Language: | English |
| ACCESSION: | WOS:001509486400001 |
| DOI: | 10.1200/JCO.2025.43.16_suppl.1088 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
